China – Government considering $280bn cash injection to stabilise crumbling stock market
China held its 1-year and 5-year Loan Prime Rate yesterday and then followed with news to prop up its equity market
- The Shanghai Composite Index hit a 5-year low with overseas funds selling $1.6bn of Chinese equities in January.
- The news lifted the index by 0.5% while the Shenzhen Component Index rose 1.38%.
- The move highlights how vulnerable Chinese markets are to overseas influence. The authorities are also considering other options.
- The one-year interest rate stands at 3.45%. Five-year rates are based on 4.2%. This is the basis for mortgage financing and refinancing.
- Chinese citizens have been slow to return to consumption and property buying since covid.
- There is some ‘speculation’ that more Chinese people are looking to move cash offshore and this may be driving Bitcoin and possibly some other crypto currencies.
- The PBoC has been looking to slow the exodus of funds out of China with the US dollar gaining 5.6% on the Yuan over the past year.
- The Yuan’s fall was not helped by a 4.6% fall in exports to $3.38tn led by price falls in rare earths and aluminium.
- A 13% fall in exports to the US led the decline as higher US interest rates combined with the reshoring of component manufacturing and a degree of global uncertainty with the war in Ukraine.
- Deflation: China is working to contain deflationary pressures despite better-than-expected GDP of 5.2%.
- CPI fell by 0.3% yoy in December though this was not as dramatic as the 0.5% fall for November. 2023 CPI rose by just 0.2% with National Bureau of Statistics of China
- Core consumer prices, excluding food and energy, increased 0.6% yoy in December.
- Property prices may well fall this year if the PBoC does not drop rates causing further deflationary pressure.
- Forums
- ASX - By Stock
- S32
- Ann: Quarterly Report December 2023
S32
south32 limited
Add to My Watchlist
1.38%
!
$2.94

Ann: Quarterly Report December 2023, page-13
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.94 |
Change
0.040(1.38%) |
Mkt cap ! $13.25B |
Open | High | Low | Value | Volume |
$2.95 | $3.01 | $2.94 | $78.78M | 26.55M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
15 | 251989 | $2.94 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.96 | 2724 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 36181 | 2.940 |
3 | 16136 | 2.920 |
3 | 6342 | 2.910 |
7 | 43875 | 2.900 |
7 | 20074 | 2.890 |
Price($) | Vol. | No. |
---|---|---|
2.970 | 4714 | 1 |
2.990 | 15000 | 2 |
3.000 | 32511 | 5 |
3.010 | 5004 | 2 |
3.020 | 60758 | 11 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
S32 (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online